Jeena Sikho Lifecare Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target

July 6, 2026
Posted by: Kunal Singla
Category: News

Jeena Sikho Lifecare CMP Rs.576. Q1 FY27E revenue Rs.245-281 Cr. PAT estimate Rs.68-86 Cr. 12-month target Rs.691-766.

Jeena Sikho Lifecare Q1 Results FY27 is coming into focus as investors position ahead of the July-August 2026 results season, with Jeena Sikho Lifecare shares trading at Rs.576 against a market capitalisation of Rs.7,153 Cr and a price-to-earnings multiple of 32.2. As a healthcare services name on the NSE and BSE, Jeena Sikho Lifecare enters the Jeena Sikho Lifecare Q1 Results FY27 print with the Street watching revenue momentum, margin trajectory and management commentary on FY27 guidance.

This Jeena Sikho Lifecare Q1 Results FY27 preview is built on a trailing-growth framework applied to the company’s Q1 FY26 base of Rs.175 Cr revenue and Rs.51 Cr net profit, using the most recent year-on-year growth signal from Q4 FY26. This Q1 prediction is a Uniresearch trailing-growth projection, not a formal analyst estimate, and should be read alongside the company’s own guidance once released.

Get Free Investment Predictions and Jeena Sikho Lifecare Research at Univest

Table of Contents

About Jeena Sikho Lifecare

Jeena Sikho Lifecare (NSE: JSLL) operates in the healthcare services space and is tracked on Univest under its NSE and BSE listings. Ahead of the Jeena Sikho Lifecare Q1 Results FY27 print, the company’s most recent reported quarter (Q4 FY26) shows revenue of Rs.219 Cr and net profit of Rs.45 Cr, forming the base against which the Jeena Sikho Lifecare Q1 Results FY27 estimates in this article are built. This Jeena Sikho Lifecare Q1 Results FY27 snapshot is intended as a starting point for research, not a substitute for the company’s own disclosures.

Jeena Sikho Lifecare Q1 FY27 Estimates

Metric	Q1 FY27E (Range)	Q1 FY26 Actual	YoY Growth
Revenue (Rs. Cr)	245-281	175	+50.0%
Net Profit / PAT (Rs. Cr)	68-86	51	+50.0%
Results Date	July-August 2026 (indicative)
12-Month Target (Uniresearch Estimate)	Rs.691-766

Univest, a SEBI-Registered Investment Advisor, Tracks Jeena Sikho Lifecare Ahead of Q1 FY27 Results

Key Catalysts to Watch

1. Occupancy and ARPOB Trends

Occupancy and ARPOB improvement across hospital and diagnostic networks is one of the primary variables that analysts are tracking ahead of Jeena Sikho Lifecare’s Q1 FY27 results and FY27 guidance. The market’s reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the Jeena Sikho Lifecare share price target or faces renewed pressure.

2. Capacity Addition

Capacity addition through new beds or centres supporting medium-term growth is one of the primary variables that analysts are tracking ahead of Jeena Sikho Lifecare’s Q1 FY27 results and FY27 guidance. The market’s reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the Jeena Sikho Lifecare share price target or faces renewed pressure.

3. Case Mix Improvement

Case mix improvement toward higher-margin specialties aiding profitability is one of the primary variables that analysts are tracking ahead of Jeena Sikho Lifecare’s Q1 FY27 results and FY27 guidance. The market’s reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the Jeena Sikho Lifecare share price target or faces renewed pressure.

Download the Univest iOS App or Univest Android App to track Jeena Sikho Lifecare’s live price and Q1 FY27 result updates.

Key Risks to the Jeena Sikho Lifecare Q1 Results FY27 Outlook

Slower occupancy ramp-up in newly added capacity affecting near-term margins.
Regulatory changes to pricing or insurance reimbursement norms.
Talent cost inflation for specialist doctors and clinical staff.

Q4 FY26 Performance Context for the Jeena Sikho Lifecare Q1 Results FY27 Print

Jeena Sikho Lifecare closed Q4 FY26 with revenue of Rs.219 Cr and net profit of Rs.45 Cr, a year-on-year revenue change of +56.9% and PAT change of +77.9% versus Q4 FY25. This base underpins the Jeena Sikho Lifecare Q1 Results FY27 projection used in this preview and should be read alongside the company’s own Jeena Sikho Lifecare Q1 Results FY27 commentary once reported.

Technical Analysis Ahead of Jeena Sikho Lifecare Q1 Results FY27

Jeena Sikho Lifecare shares last traded at Rs.576. For the current 52-week high and low, support and resistance levels, investors should check the live chart on the Univest app or the NSE website, since these levels move intraday and are not reproduced here to avoid stale data.

Share Price Target Based on the Jeena Sikho Lifecare Q1 Results FY27 Outlook

3-6 Month Target

Over a 3-6 month horizon, the Jeena Sikho Lifecare Q1 Results FY27 trailing-growth framework points to a range of Rs.603-649 for Jeena Sikho Lifecare, contingent on the Jeena Sikho Lifecare Q1 Results FY27 print matching or beating the trailing growth trend.

12-Month Target

The 12-month target (Uniresearch estimate) tied to this Jeena Sikho Lifecare Q1 Results FY27 view for Jeena Sikho Lifecare works out to Rs.691-766, built on the same trailing revenue growth trend and current valuation multiple. Tracking with a constructive bias is how Univest research categorises the stock heading into Jeena Sikho Lifecare Q1 Results FY27, not a formal Buy or Sell call.

FY27-28 Outlook

Looking out to FY27-28, a sustained continuation of the growth trajectory implied by this Jeena Sikho Lifecare Q1 Results FY27 analysis would put Jeena Sikho Lifecare in a Rs.789-893 range, though this is sensitive to sector-wide demand, cost trends and any change in the company’s competitive position.

What to Watch in the Jeena Sikho Lifecare Q1 Results FY27 Print

Revenue and PAT versus the Jeena Sikho Lifecare Q1 Results FY27 estimate range in this preview.
Management commentary on FY27 growth guidance and margin trajectory relevant to the Jeena Sikho Lifecare Q1 Results FY27 narrative.
Occupancy and ARPOB improvement across hospital and diagnostic networks
Slower occupancy ramp-up in newly added capacity affecting near-term margins

Conclusion on Jeena Sikho Lifecare Q1 Results FY27

Jeena Sikho Lifecare enters the Q1 FY27 results season trading at Rs.576, with the 12-month Uniresearch target range of Rs.691-766 reflecting a tracking with a constructive bias stance. Investors tracking the Jeena Sikho Lifecare Q1 Results FY27 print should watch the catalysts and risks above and consult a SEBI-registered advisor before making investment decisions around the results.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs on Jeena Sikho Lifecare Q1 Results FY27

When are Jeena Sikho Lifecare Q1 FY27 results expected?

Ans. Jeena Sikho Lifecare’s Q1 FY27 results are expected in the July-August 2026 window, in line with the broader NSE and BSE results season for the quarter ending June 2026.

What is the Jeena Sikho Lifecare Q1 FY27 revenue estimate?

Ans. The Uniresearch trailing-growth estimate for Jeena Sikho Lifecare’s Q1 FY27 revenue is Rs.245-281 Cr, based on the Q1 FY26 base of Rs.175 Cr.

What is the Jeena Sikho Lifecare share price target?

Ans. The 12-month Uniresearch estimate for Jeena Sikho Lifecare share price target is Rs.691-766, based on trailing growth and current valuation multiples.

Is Jeena Sikho Lifecare a good buy before Q1 FY27 results?

Ans. Jeena Sikho Lifecare is tracking with a constructive bias heading into Q1 FY27 results. Investors should weigh the catalysts and risks in this article and consult a SEBI-registered advisor before investing.

What should investors watch in Jeena Sikho Lifecare’s Q1 FY27 results?

Ans. Key items include revenue and PAT versus estimates, management commentary on FY27 guidance, and occupancy and ARPOB improvement across hospital and diagnostic networks.

Where can I track Jeena Sikho Lifecare share price live?

Ans. Jeena Sikho Lifecare share price can be tracked live on the Univest app and website, along with research updates from SEBI-registered analysts.

Author: Kunal Singla

Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.